longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

GRDN

GRDN
41.2101.39%( -0.580 )

LongbridgeAI

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

benzinga_article
Sep 23, 2026 at 11:49 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Top Wall Street analysts initiated bullish coverage on five stocks: HCA Healthcare (Outperform, $495 PT), Guardian Pharmacy Services (Overweight, $52 PT), Toro Co (Outperform, $120 PT), Marvell Technology (Buy, $270 PT), and Pulse Biosciences (Buy, $70 PT). These initiations by BMO, Keybanc, Oppenheimer, Seaport Global, and BTIG set positive outlooks for the respective companies.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • BMO Capital analyst Sean Dodge initiated coverage on HCA Healthcare Inc (NYSE:HCA) with an Outperform rating and announced a price target of $495. HCA Healthcare closed at $438.12 on Tuesday. See how other analysts view this stock.
  • Keybanc analyst Zach Haggerty initiated coverage on Guardian Pharmacy Services Inc (NYSE:GRDN) with an Overweight rating and announced a price target of $52. Guardian Pharmacy shares closed at $44.67 on Tuesday. See how other analysts view this stock.
  • Oppenheimer analyst Kristen Owen initiated coverage on Toro Co (NYSE:TTC) with an Outperform rating and announced a price target of $120. Toro closed at $94.52 on Tuesday. See how other analysts view this stock.
  • Seaport Global analyst Jay Goldberg initiated coverage on Marvell Technology Inc (NASDAQ:MRVL) with a Buy rating and announced a price target of $270. Marvell Technology shares closed at $262.36 on Tuesday. See how other analysts view this stock.
  • BTIG analyst Marie Thibault initiated coverage on Pulse Biosciences Inc (NASDAQ:PLSE) with a Buy rating and announced a price target of $70. Pulse Biosciences closed at $52.69 on Tuesday. See how other analysts view this stock.

Considering buying HCA stock? Here’s what analysts think:

Photo via Shutterstock

Login to unlock965characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Sep 19, 2026 at 05:15 PMPrediction: This Nvidia-Backed Artificial Intelligence (AI) Stock Could 10X by 2033
  • Sep 9, 2026 at 07:00 PMAMD Leads As Semiconductors And Technology Dominate Order Flow Activity
  • Sep 8, 2026 at 11:07 PMMarvell shares have soared 241% in a year. CEO says this is a key reason why
  • Sep 1, 2026 at 09:20 AMBroadcom vs. Marvell: Which AI Chip Stock Is the Better Buy?
  • Aug 29, 2026 at 01:00 PM5 Stocks Investors Couldn't Stop Buzzing About This Week: NVDA, MRVL, CRM and More

Related Stocks

Toro

Toro

USTTC

+0.32%

Marvell Tech

Marvell Tech

USMRVL

+1.15%

Guardian Pharmacy Services

Guardian Pharmacy Services

USGRDN

-1.39%